Alpine Global Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5K | Buy |
+17,731
| New | +$17.5K | ﹤0.01% | 140 |
|
|
2024
Q3 | – | Sell |
-183,922
| Closed | -$408K | – | 251 |
|
|
2024
Q2 | $408K | Buy |
+183,922
| New | +$408K | 0.07% | 202 |
|
|
2022
Q4 | – | Sell |
-10,150
| Closed | -$68K | – | 505 |
|
|
2022
Q3 | $68K | Hold |
10,150
| – | – | 0.02% | 132 |
|
|
2022
Q2 | $65K | Hold |
10,150
| – | – | 0.02% | 160 |
|
|
2022
Q1 | $47 | Sell |
10,150
-8,932
| -47% | -$41 | 0.01% | 315 |
|
|
2021
Q4 | $95K | Buy |
+19,082
| New | +$95K | 0.01% | 659 |
|